Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Pasithea Therapeutics Corp. (KTTA) AI Dilution Summary

Updated Sep 28, 2026

Cash was $45,663,782 at 2026-06-30 against estimated monthly burn of $1,569,172. Dilution here is driven primarily by the December 2025 Pre-Funded Warrants, covering 54,828,835 shares at a fixed exercise price of $0.0010 per share. The share count underlying them is set by contract and does not move with the market price.